We are investigating how ziltivekimab may improve heart health in people who have had a heart attack compared to a placebo. This study aims to see if it can reduce serious heart-related issues.
Health conditions and diseases that the clinical trial is designed to study and treat.
A heart attack, or acute myocardial infarction (AMI), occurs when blood flow to a part of the heart is blocked, leading to damage to the heart muscle. This can happen in two forms: ST-elevation myocardial infarction (STEMI) and non-ST-elevation myocardial infarction (NSTEMI).
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.